Defining subsets of patients with chronic bronchitis.
Wilson
R
R
Host Defence Unit, National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, London, United Kingdom.
Wilson
C B
CB
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000503:physiopathology; D001991:Bronchitis / Q000145:classification* / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology; D002908:Chronic Disease; D003371:Cough / Q000503:physiopathology; D004417:Dyspnea / Q000503:physiopathology; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000503:physiopathology; D012307:Risk Factors; D012907:Smoking / Q000503:physiopathology; D013183:Sputum / Q000378:metabolism
D000900:Anti-Bacterial Agents